article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. Caroline Peachey is Editor of European Pharmaceutical Review.

article thumbnail

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

Tune in and discover how one individual’s dedication can truly make a difference in the world of healthcare. It’s hard to divvy all that because we work with medical affairs and medical science liaisons. By 2027, they are projected to be about $10 billion. We have two managers.